Lithium (Lithobid): Uses, Dosing, Side Effects, Levels & Toxicity

What It's Used For

Lithium is a frontline mood stabilizer for bipolar disorder, especially mania and long-term relapse prevention. It can be used alone or combined with an antipsychotic or antiseizure med during severe episodes. In psychiatry, lithium is also used off-label as an add-on for hard-to-treat unipolar depression and in postpartum psychosis—always with blood level monitoring because the line between “working” and “toxic” can be thin.

Primary Indications

Bipolar disorder: acute mania and mixed features, and maintenance to prevent manic/depressive relapseMajor depressive disorder (unipolar): augmentation when depression isn’t responding (off-label)Postpartum psychosis: typically combined with an antipsychotic (off-label)

Off-Label Uses

Acute hypomaniaAcute bipolar major depression (alternative agent)Unipolar depression augmentationPostpartum psychosis

How Fast It Works

Lithium’s blood levels stabilize in days, but mood stabilization is usually measured in days to weeks—especially for relapse prevention. This is a lab-guided medication: you don’t guess the dose based on vibes; you confirm the trough level and match it to symptoms and side effects.

15-60 minutes

Oral solution can reach peak levels faster (not a reason to expect instant mood effects)

0.5-3 hours

Peak for immediate-release (IR)

2-6 hours

Peak for extended-release (ER)

~5 days

Typical time to check a trough after a dose change (steady-ish state for monitoring)

18-36 hours

Typical adult half-life (often longer in older adults)

Safe Discontinuation

Lithium is one of those meds where stopping too fast can backfire—especially if it was doing real relapse prevention work. If you’re discontinuing for non-emergency reasons, a gradual taper helps reduce the risk of mood episode recurrence. If lithium is being stopped because of significant adverse effects or toxicity, safety comes first and the plan changes.

Key Points

If switching to another medication during acute treatment, one approach is tapering lithium over 1 to 2 weeks (for example, decreasing by 300 mg each day or every other day) while the replacement medication is started and stabilized.
For discontinuing maintenance therapy in bipolar disorder, taper over several weeks to months when feasible to help detect relapse early and reduce rebound recurrence risk.
If discontinuation is due to toxicity or serious medical adverse effects, the taper may be faster or immediate—this is a medical decision based on risk.
After stopping, monitor for early relapse signs (sleep reduction, increased energy, irritability, racing thoughts, impulsivity) and have a safety plan.

Dosing Information

Adult Dosing

bipolar mania initial: IR or ER: 600 to 900 mg/day PO based on formulation (IR in 2 to 3 divided doses; ER in 2 divided doses)

bipolar mania titration: Increase by 300 to 600 mg every 1 to 5 days based on response, tolerability, and serum lithium concentration

bipolar mania typical: 900 mg/day to 1,800 mg/day PO in 1 to 3 divided doses (based on tolerability and formulation)

bipolar mania target level: Typical therapeutic response: 0.8 to 1.2 mEq/L during acute mania; some patients respond at ~0.6 mEq/L

maintenance typical: Continue the regimen that controlled the acute episode; many patients maintain at lower doses/levels (often 0.6 to 1.0 mEq/L), individualized to relapse prevention vs side effects

mdd augmentation initial: IR or ER: 300 to 600 mg/day PO in 1 to 2 doses (if ≤300 mg/day, may start once daily regardless of formulation)

mdd augmentation titration: Increase every 1 to 5 days as tolerated to a target of 600 mg/day to 1,200 mg/day, guided by symptoms and levels

mdd augmentation target level: Common targets: ~0.6 to 0.9 mEq/L (some patients respond at lower levels)

postpartum psychosis initial: 300 mg PO once daily; may increase to 300 mg PO twice daily on day 2

postpartum psychosis adjustment: After ~5 days, adjust based on clinical response, tolerability, and serum level; typically used with an antipsychotic

formulation conversion: IR ↔ ER: use the same total daily dose; initially give IR in 2 to 3 doses and ER in 2 doses; after several weeks stable, may consolidate to a single bedtime dose if appropriate

bedtime consolidation note: Once-daily dosing can raise trough levels ~10% to 26% compared with divided dosing at the same total dose—dose adjustments may be needed

renal impairment adjustment: CrCl ≥60 mL/min: no adjustment; CrCl 30 to <60: start low (150 to 300 mg/day in 1 to 2 doses), titrate slowly with frequent levels; CrCl <30: avoid

hemodialysis adjustment: Avoid if possible; if necessary: 300 mg PO three times weekly after dialysis with careful titration and level monitoring (post-dialysis levels are falsely low due to rebound)

peritoneal dialysis adjustment: Avoid if possible; if necessary: start very low (eg, 150 mg daily) and titrate with close monitoring

older adult note: Start lower and target lower serum levels when possible (often ~0.4 to 0.8 mEq/L) due to higher toxicity risk

Simple Explanation

Lithium dosing is really “dose + blood level + how you feel.” Two people can take the same mg dose and have very different lithium levels because kidneys, hydration, salt, and interacting meds change clearance. That’s why labs are part of the prescription, not optional add-ons.

Available Formulations

Capsules (lithium carbonate): 150 mg, 300 mg, 600 mg
Tablets (lithium carbonate): 300 mg
Extended-release tablets (lithium carbonate): 300 mg, 450 mg (brand: Lithobid 300 mg)
Oral solution (lithium citrate): 8 mEq/5 mL (note: availability can vary by country/market over time)

Critical Safety Information

Lithium has a narrow safety window. Toxicity can happen near therapeutic levels—especially with dehydration, kidney problems, or drug interactions.

→Get your blood levels the way your prescriber tells you (usually a 12-hour trough). Don’t freestyle the timing.
→Hydration and salt need to be steady. Big changes = lithium level changes.
→If you get stomach flu, vomiting/diarrhea, fever, heavy sweating, or you can’t keep fluids down: treat it like a lithium emergency and call your clinician—levels can spike fast.
→Avoid starting NSAIDs (like ibuprofen/naproxen) without checking with your prescriber—these can raise lithium levels.
→Know toxicity warning signs: worsening tremor, severe nausea/vomiting/diarrhea, unsteady walking, slurred speech, confusion, heavy sedation.
→ER tablets must be swallowed whole—don’t crush or chew.
→If you’re planning pregnancy or become pregnant, don’t stop abruptly on your own. Call immediately so dosing and monitoring can be adjusted safely.

Side Effects

Lithium side effects are often dose/level-related. Some are annoying but manageable (GI upset, tremor, thirst). Others are long-game risks that require lab monitoring (kidney, thyroid, calcium/parathyroid). Toxicity is the big one to respect.

Common Things People Notice

Thirst and peeing more than usual (polyuria/polydipsia)
Hand tremor (often dose-related)
Nausea or diarrhea (especially early on)
Cognitive slowing or “fog” (varies a lot person to person)
Weight gain (can happen over time)
Thyroid changes (hypothyroidism is common in long-term use)
Kidney effects over years (risk increases with duration and toxicity episodes)

Common Side Effects

Common

GI upset (nausea, diarrhea)— Early nausea is common and may improve. Taking with food can help. If you have severe nausea/vomiting/diarrhea, think “possible high level,” especially if you’re dehydrated.

Common (often described in ~1 in 4 patients)

Tremor— A mild hand tremor can show up early. If tremor suddenly worsens or turns coarse, that’s a toxicity red flag—especially if you also feel wobbly, nauseated, or confused.

Common (especially with long-term use)

Polyuria / polydipsia— More thirst and more urination can happen early or later. It can be mild or quality-of-life annoying. Persistent, extreme symptoms can be part of nephrogenic diabetes insipidus and need evaluation.

Variable

Cognitive dulling / slowed thinking— Some people feel a mental “slowing” or less creative intensity. If it’s impacting life, dose/target level can often be adjusted—don’t just quit.

Common

Weight gain— Weight gain can happen over time. Sometimes it’s indirect (more sugary drinks from thirst, fluid changes, or thyroid slowing). Monitoring weight and thyroid helps catch this early.

Serious side effects

Lithium toxicity: worsening tremor, severe GI symptoms, ataxia/unsteady gait, slurred speech, confusion, lethargy; can progress to seizures, coma, death if untreated
SILENT syndrome (rare): persistent neurologic injury after toxicity episodes
Cardiac conduction issues: bradycardia, arrhythmias, ECG changes; possible unmasking of Brugada pattern
Nephrogenic diabetes insipidus with hypernatremia risk: severe thirst/urination, dehydration, neurologic symptoms
Progressive kidney impairment over long-term exposure (risk increases with duration and toxicity episodes)
Hypothyroidism (can worsen depressive symptoms and fatigue; can be misread as mood relapse)
Hyperparathyroidism/hypercalcemia: fatigue, weakness, stones, bone issues; can present with depressive symptoms
Pseudotumor cerebri (rare): headache, vision changes, papilledema; can lead to vision loss if missed
Serotonin syndrome (rare, usually with serotonergic combinations): agitation, confusion, autonomic instability, tremor/rigidity, hyperreflexia, diarrhea, fever

Critical Drug Interactions

Lithium interactions are a big deal because many common meds can raise lithium levels by reducing kidney clearance. If lithium levels rise, toxicity can hit fast—sometimes even without a dose change.

With: NSAIDs (ibuprofen, naproxen, many prescription NSAIDs)

Risk: Can increase lithium levels by reducing renal clearance → toxicity risk

Action: Avoid routine NSAID use unless your prescriber specifically okays it and levels are monitored. If an NSAID is started, lithium level may need re-check and dose adjustment.

With: ACE inhibitors / ARBs (common blood pressure meds)

Risk: Can increase lithium levels → toxicity risk

Action: Use caution and monitor levels closely, especially after starting or changing doses.

With: Diuretics (especially thiazides; also other diuretics can matter)

Risk: Increase lithium levels and toxicity risk; sodium depletion worsens this

Action: Often avoid. If unavoidable, lithium dose reduction and close monitoring are typically needed.

With: Serotonergic agents (SSRIs/SNRIs, TCAs, triptans, tramadol, fentanyl, buspirone, St. John’s wort, tryptophan, MAOIs)

Risk: Serotonin syndrome (rare but potentially life-threatening)

Action: Monitor closely for agitation, confusion, sweating, fever, tremor/rigidity, hyperreflexia, diarrhea. Stop meds and seek urgent care if symptoms appear.

With: Other CNS depressants or neuroactive meds (antipsychotics, antiseizure meds, sedative-hypnotics)

Risk: Additive neurologic effects (sedation, coordination problems) and can complicate toxicity recognition

Action: Start low, go slow, and watch for neurotoxicity signs (worsening gait, confusion, slurred speech).

With: Dehydration / sodium depletion (GI illness, heavy sweating, low salt intake, drastic diet changes)

Risk: Raises lithium levels and toxicity risk without any medication interaction

Action: Maintain steady fluids and salt. If sick with vomiting/diarrhea or unable to hydrate, contact your prescriber urgently.

Pregnancy, Breastfeeding, Special Groups

Lithium can be used across different life stages, but the monitoring and risk-benefit math changes a lot in pregnancy, postpartum, older adulthood, and kidney disease. For many patients, the biggest risk isn’t lithium itself—it’s relapse from stopping an effective mood stabilizer without a plan.

👶Pregnancy

Lithium crosses the placenta and fetal levels can be similar to maternal levels. First-trimester exposure is associated with increased risk of cardiac malformations (including Ebstein anomaly), though the absolute risk may be low. Consider fetal echocardiography in the second trimester (16–20 weeks) if first-trimester exposure occurs. Pregnancy increases lithium renal clearance, so doses often need adjustment to maintain therapeutic effect; levels are typically checked every 2 to 4 weeks until 34 weeks, then at least weekly until delivery. Many guidelines suggest reducing or holding lithium 24 to 48 hours before planned delivery or at labor onset to reduce maternal/neonatal toxicity risk, then restarting postpartum with level-guided dosing. Shared decision-making matters because untreated bipolar disorder increases pregnancy/postpartum risks, including postpartum psychosis.

🤱Breastfeeding

Lithium is present in breast milk, and infant serum levels can be significant (sometimes up to ~50% of maternal levels). Some guidelines allow breastfeeding only in carefully selected situations (clinically stable parent, full-term healthy infant, strong adherence, and ability to monitor). If breastfeeding occurs, infant monitoring is essential (infant lithium level, thyroid and renal function, weight/growth, neurodevelopment). Watch for infant toxicity signs like cyanosis, ECG changes, abnormal tone, hypothermia, poor feeding, lethargy; discontinue breastfeeding if toxicity occurs. Some sources and the manufacturer do not recommend breastfeeding on lithium due to variability and risk.

👧Children & Adolescents (Under 18)

Lithium is used in pediatric bipolar disorder with serum level monitoring. Immediate-release products are labeled for acute mania/mixed episodes and maintenance in ages ≥7 years; extended-release is labeled for ages ≥12 years. Dosing is weight- and level-guided, with careful titration and avoidance in significant renal impairment.

👴Older Adults (65+)

Older adults are more vulnerable to toxicity due to age-related renal clearance changes and comorbid meds. Start lower, titrate slower, and consider lower target levels (often ~0.4 to 0.8 mEq/L). Lithium is considered potentially inappropriate in older adults with QTc prolongation risk and requires extra ECG and renal monitoring when used.

🔬Liver Impairment

No manufacturer-provided dose adjustment; lithium is not hepatically metabolized. Practical management focuses on renal function, hydration, and interactions.

💧Kidney Impairment

Lithium is primarily renally cleared. Reduced kidney function increases toxicity risk and requires lower starting doses, slower titration, and frequent levels. Avoid when CrCl <30 mL/min. Dialysis patients are generally poor candidates unless benefits clearly outweigh risks and monitoring is highly specialized.

Clinical Monitoring

Before starting: Confirm that prompt, accurate serum lithium monitoring is available. Lithium toxicity can occur close to therapeutic levels.
Serum lithium trough levels: Prefer a 12-hour trough (sometimes 8–12 hours if logistics require). Check ~5 days after dose changes. Once stable, recheck every 3 to 6 months or as clinically indicated; more often with interacting meds, illness, dehydration, or kidney disease.
Renal function (BUN/SCr/eGFR): Baseline; every 2 to 3 months during the first 6 months; then at least annually if stable (more often if risk factors or changes occur).
Thyroid function (TSH ± free T4): Baseline; 1 to 2 times in first 6 months; then at least annually if stable. Watch for fatigue, cognitive slowing, weight gain, and depressive symptoms that can mimic relapse.
Calcium (and PTH if indicated): Baseline; recheck 2 to 6 weeks after initiation; then every 6 to 12 months. Monitor for hypercalcemia symptoms (fatigue, weakness, constipation, stones, bone pain, mood changes).
Electrolytes and fluid status: Baseline and periodically; extra vigilance during GI illness, heat exposure, heavy sweating, or major diet changes.
ECG: Baseline for patients >40 or with cardiac risk factors; repeat as clinically indicated. Watch for bradycardia, conduction changes, and symptoms like syncope/palpitations.
Weight and metabolic tracking: Baseline and periodically; address thirst-driven high-calorie beverages and hypothyroidism as contributors.
Neurotoxicity and early toxicity symptoms: New/worsening tremor, diarrhea/vomiting, ataxia, slurred speech, confusion, heavy sedation—treat these as urgent, especially if dehydrated or after starting NSAIDs/ACEi/ARB/diuretics.
Polyuria/polydipsia: Track severity and impact; evaluate for nephrogenic diabetes insipidus when persistent or severe.
Reproductive monitoring: Pregnancy test prior to initiation for patients who could become pregnant. If pregnant: lithium levels every 2–4 weeks until 34 weeks, then at least weekly until delivery; at delivery; twice weekly in first 2 postpartum weeks; then again at ~4 weeks postpartum (plus renal labs as indicated).
Safety checks: Avoid dosing errors (mg vs mEq confusion). 300 mg lithium carbonate (or equivalent citrate) contains about 8 mEq of lithium ion—prescriptions should be written in mg to avoid mistakes.

How Well It Works

Lithium is one of the most established mood stabilizers in psychiatry for bipolar disorder. In real-world practice, the main “efficacy” question is whether you’re in a therapeutic trough range that matches your phase of illness (acute vs maintenance) and whether you can tolerate it without drifting into toxicity. It’s a medication where monitoring is part of the treatment, not an optional extra.

Mechanism of Action

Lithium’s exact mood-stabilizing mechanism isn’t fully pinned down. In plain terms, it seems to change how brain cells communicate and how intracellular signaling pathways behave. It affects ion transport and multiple second-messenger systems (including pathways tied to the phosphatidylinositol cycle) and may have neuroprotective effects that support more stable mood circuitry over time.

Place in Treatment Algorithm

Lithium is a cornerstone option for bipolar disorder—especially for acute mania/mixed states and for maintenance relapse prevention. In acute severe mania, it’s often paired with an antipsychotic or an antiseizure medication for faster control. Lithium is also used off-label as augmentation in treatment-resistant depression and in postpartum psychosis (often with an antipsychotic). The clinical reality: lithium works best when the monitoring plan is solid, interactions are respected, and hydration/salt are stable.

Questions people ask

What is lithium used for in psychiatry?

Lithium is mainly used for bipolar disorder—especially acute mania/mixed episodes and long-term maintenance to prevent relapse. It’s also used off-label as an add-on for treatment-resistant unipolar depression and in postpartum psychosis (usually alongside an antipsychotic).

Why does lithium require blood tests?

Because lithium has a narrow safety window. The dose that helps can be close to the dose that harms. Blood levels (usually a 12-hour trough) confirm you’re in the therapeutic range and help prevent toxicity—especially when dehydration, kidney changes, or drug interactions can push levels up.

What lithium level is considered therapeutic?

Targets depend on the situation. In acute mania, many patients respond around 0.8–1.2 mEq/L. For maintenance, targets are often lower (commonly 0.6–1.0 mEq/L). Older adults frequently need lower targets (for example, 0.4–0.8 mEq/L) to reduce toxicity risk. Your symptoms and side effects matter just as much as the number.

What are early signs of lithium toxicity?

Watch for new or worsening shaking, bad nausea, vomiting or diarrhea, unsteadiness or clumsiness, slurred speech, confusion and heavy sleepiness. Toxicity risk rises with dehydration, kidney problems and interacting medicines. If these show up, contact your clinician urgently and don’t take extra doses.

What medications interact with lithium the most?

The big ones are NSAIDs (like ibuprofen/naproxen), ACE inhibitors/ARBs (common blood pressure meds), and diuretics—these can raise lithium levels by reducing kidney clearance. Always check before starting them, and expect that your prescriber may re-check lithium levels after medication changes.

Does lithium help with anxiety or insomnia?

Lithium isn’t a primary anxiety or insomnia medication. Some people feel calmer once mood is stabilized, but it’s not a fast sedative and it’s not typically prescribed just for sleep. If insomnia or agitation is part of mania, lithium can help by treating the mood episode over time, often alongside other medications early on.

Can lithium cause weight gain?

Yes, it can. Weight gain can happen over time, sometimes related to increased thirst (more sugary drinks), fluid changes, or lithium-related hypothyroidism. Monitoring weight and thyroid labs helps catch contributors early.

Can lithium affect the kidneys?

Yes. Lithium is cleared by the kidneys and can affect kidney function over long-term use. That’s why kidney labs (BUN/creatinine/eGFR) are monitored regularly. Risk rises with longer duration, higher serum levels, and especially with repeated toxicity episodes.

Can lithium affect the thyroid or calcium?

Yes. Hypothyroidism is common in long-term use and can mimic depression or fatigue. Lithium can also contribute to hyperparathyroidism/hypercalcemia over time. That’s why thyroid labs and calcium (and sometimes PTH) are monitored periodically.

Is lithium safe in pregnancy?

Lithium can be used in pregnancy, but it requires careful shared decision-making and frequent monitoring. First-trimester exposure is linked with increased risk of certain cardiac malformations, though the absolute risk may be low. Pregnancy changes kidney clearance, so lithium levels are checked often and doses may need adjustment. Stopping lithium abruptly can raise relapse risk, including postpartum psychosis—so changes should be guided by your prescriber.

Can I breastfeed on lithium?

This is complicated. Lithium passes into breast milk and infant levels can be significant. Some guidelines allow breastfeeding only in carefully selected cases with close infant monitoring (infant lithium levels, kidney/thyroid labs, weight/growth, and toxicity symptoms). The manufacturer does not recommend breastfeeding on lithium. If breastfeeding is considered, it should be a structured plan—not a casual decision.

How do I stop lithium safely?

If it’s not an emergency, tapering is usually preferred to reduce relapse risk. During an acute medication switch, one approach is tapering over 1–2 weeks (for example, decreasing by 300 mg each day or every other day). For maintenance discontinuation in bipolar disorder, taper over weeks to months when feasible. If stopping because of toxicity or serious side effects, the plan can be faster—your clinician should direct it.